Cytiva News

  1. Cobra Biologics, GE Healthcare And Centre For Process Innovation Collaborate To Advance Gene Therapy 9/25/2018

    Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals, announced a collaboration with the Centre for Process Innovation (CPI), a UK-based technology innovation centre and GE Healthcare Life Sciences. The three-way partnership, funded by a £570K Innovate UK grant, aims to increase the robustness and reduce costs for the manufacturing of adeno-associated virus (AAV) vectors, a delivery vehicle used for emerging gene therapy treatments. The gene therapy area has been developing rapidly and while only a small number of treatments are already approved for use, more than 200 clinical trials are underway.

  2. GE's New Factory-In-A-Box Accelerates The Production Of Viral Vector Based Therapeutics 4/17/2018

    GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene and cell therapies.

  3. CBMG Accelerates Cell Therapy Manufacturing With GE Healthcare's New Start-To-Finish Solution 1/18/2018

    Cellular Biomedicine Group Inc. (CBMG or the Company), a leading clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer, has announced its plan to configure part of its facility in Shanghai with GE Healthcare’s FlexFactory™ platform, which will be designed to speed up manufacturing timelines for its cell therapy clinical trials and commercial launch.

  4. GE Healthcare Acquires Bioprocessing Start-Up Puridify 11/24/2017

    GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production.

  5. RiboBio And GE Healthcare Enter Into A Strategic Partnership For Oligonucleotide Drug Development And Manufacturing 11/21/2017

    At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life Sciences ("GE") held a strategic partnership signing ceremony

  6. Rentschler Biotechnologie Expands European Manufacturing Capabilities With GE Healthcare Life Sciences Bioprocess Technologies 4/14/2015

    GE Healthcare Life Sciences a provider of tools, technologies and services to the biopharmaceutical manufacturing industry and Rentschler Biotechnologie GmbH, a leading contract manufacturing and development organization (CDMO) for biopharmaceuticals, announced recently a joint celebration to mark the handover of GE Healthcare’s 1000th ÄKTAprocess and the expansion of Rentschler’s biopharmaceutical manufacturing capabilities in Laupheim, Germany.

  7. GE Healthcare Life Sciences Named As Finalist For Four Bioprocess Industry Awards 10/3/2014

    GE Healthcare Life Sciences  announced recently that the company has been shortlisted as a finalist for four BioProcess International (BPI) Awards1.

  8. GE Healthcare Launches Xuri™ IL-2 Growth Factor For The Reliable Activation And Expansion Of T-lymphocytes 5/14/2014

    Xuri™ IL-2 is a dedicated cell therapy ancillary product for the ex vivo cultivation of T-lymphocytes. Xuri IL-2’s defined level of biological activity removes the need for revalidation of each lot and strongly improves reproducibility, thereby minimizing process development time and improving scale out capacity.

  9. Nanotherapeutics Selects GE Healthcare Life Sciences Technologies For Advanced Development And Manufacturing Center 1/22/2014

    GE Healthcare recently announced that biopharmaceutical company Nanotherapeutics, Inc. has selected GE Healthcare Life Sciences' FlexFactory biomanufacturing platform to perform a central role in its Advanced Development and Manufacturing (NANO-ADM) Center at Alachua, Florida, USA.

  10. GE Healthcare Life Sciences To Build KUBio Modular Biopharmaceutical Factory For JHL Biotech In China 9/25/2013

    GE Healthcare Life Sciences, a business unit of GE Healthcare, and JHL Biotech, a provider of biopharmaceutical process development and manufacturing services, recently announced that a KUBio™ modular biopharmaceutical factory will be built in China for JHL Biotech.